AM Best Affirms Credit Ratings of DB Insurance Co., Limited
HONG KONG--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A (Excellent) and the…
4 years ago
Wire Stories
The APAC Pharmacy Automation Industry is Projected to Reach $725 Million by 2027 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems,…
4 years ago
LTI Constant Currency Revenues Grow 26.6% YoY; Net Profits up 27.7% YoY
MUMBAI, India--(BUSINESS WIRE)--$LTI #LTI--Larsen & Toubro Infotech (BSE code: 540005, NSE: LTI), a global technology…
4 years ago
Vivos Therapeutics Announces Multiple Regulatory Clearances in Australia for Its Entire Line of Oral Appliances
Australia clears Vivos technology to treat obstructive sleep apnea for all ages and regardless of…
4 years ago
Gilat Awarded Order of Over $7M from Tier-1 Mobile Network Carrier in APAC for 4G Cellular Backhaul Network Expansion
PETAH TIKVA, Israel, July 14, 2022 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT,…
4 years ago
Kazakhstan HnB, Oral Tobacco and Nicotine Pouch Market Regulation Report 2022 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Kazakhstan: HnB, Oral Tobacco and Nicotine Pouch Regulation" report has been added to…
4 years ago
Genius Group Welcomes Dr. David Vierra as Interim President of the University of Antelope Valley
SINGAPORE--(BUSINESS WIRE)--$GNS #edtech--Genius Group Limited (“Genius Group” or the “Company”) (NYSE American: GNS), a world-leading…
4 years ago
Global Chronic Norovirus Enteritis Epidemiology Forecast to 2032 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Chronic Norovirus Enteritis- Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's…
4 years ago
BeiGene Provides Regulatory Update on the U.S. Biologics License Application (BLA) for PD-1 Inhibitor Tislelizumab in 2L ESCC
FDA Defers Action on BLA Until Required Inspections Can Be Completed Due to COVID Travel…
4 years ago
SINOVAC COVID-19 Vaccine Is Authorized for Emergency Use in Kids Aged 3-5 In Brazil
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical…
4 years ago